Medeze Group Valuation

Q: What is the Fair Price of MEDEZE-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

MEDEZE-R (THB10) is trading above our estimate of [[fair value]] (THB3.03)

Is MEDEZE-R undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of MEDEZE-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: MEDEZE-R (THB10) is trading above our estimate of fair value (THB3.03)

Significantly Below Fair Value: MEDEZE-R is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for MEDEZE-R?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for MEDEZE-R. This is calculated by dividing MEDEZE-R's market cap by their current preferred multiple.
What is MEDEZE-R's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	฿10.68b

MEDEZE-R key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	13.4x
Enterprise Value/EBITDA	29.8x
PEG Ratio	1.6x

Price to Earnings Ratio vs Peers

How does MEDEZE-R's PE Ratio compare to its peers?

The above table shows the PE ratio for MEDEZE-R vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	25.7x
KLINIQ Klinique Medical Clinic	23.6x	18.5%	฿7.0b
SAFE Safe Fertility Group	18.7x	13.2%	฿4.3b
GFC Genesis Fertility Center	18.5x	14.8%	฿1.7b
BKGI Bangkok Genomics Innovation	42.1x	26.2%	฿1.6b
MEDEZE-R Medeze Group	39.5x	25.0%	฿10.7b

Price-To-Earnings vs Peers: MEDEZE-R is expensive based on its Price-To-Earnings Ratio (39.5x) compared to the peer average (25.7x).

Price to Earnings Ratio vs Industry

How does MEDEZE-R's PE Ratio compare vs other companies in the TH Healthcare Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	10.7%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	10.7%
	n/a	n/a	n/a

No more companies

Price-To-Earnings vs Industry: MEDEZE-R is expensive based on its Price-To-Earnings Ratio (39.5x) compared to the TH Healthcare industry average (23x).

Price to Earnings Ratio vs Fair Ratio

What is MEDEZE-R's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MEDEZE-R PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	39.5x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate MEDEZE-R's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.